Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications (Q26996059)

William W. Tseng

series ordinal

2

1 reference

language of work or name

1 reference

2014

1 reference

1 reference

64

1 reference

PubMed

issue

3

1 reference

PubMed

page(s)

195-206

1 reference

Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience

PubMed

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Clinical patterns of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

"Stealth" melanoma cells in histology-negative sentinel lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Nodal nevi and cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prediction of nonsentinel lymph node status in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Systematic review of sentinel lymph node mapping procedure in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Update on sentinel lymph node evaluation in gynecologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Sentinel node biopsy in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Melanoma recurrence patterns after negative sentinel lymphadenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Unique patterns of metastases in common and rare types of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating tumor cells as therapy-related biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Disseminated and circulating tumor cells: Role in effective cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating tumour cells in cancer patients: challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Microfluidics and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Disseminated tumour cells as a prognostic biomarker in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Biology and significance of circulating and disseminated tumour cells in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Role of circulating tumor cells and disseminated tumor cells in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Tumor cell dissemination: emerging biological insights from animal models and cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Biologic challenges in the detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Does tumour dormancy offer a therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Controversies in clinical cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Premetastatic niche: ready for new therapeutic interventions?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Lymphocyte Composition and Distribution in Inflammatory, Well-differentiated Retroperitoneal Liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217

Incidental findings in negative sentinel lymph nodes of patients with malignant melanoma: report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21217